Home All News Page 51

All News

Internet And Biotech Related News

Dalrada, Biotech Stock Review

Dalrada (DFCO) Announces Form S-1 Registration Declared Effective by SEC

SAN DIEGO , Nov. 3, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), is pleased to announce that its Form S-1 registration statement has been declared effective by...
Teledoc, Biotech Stock Review

Nothing Quite Like Telehealth. Teledoc (TDOC) Price Targets Raised.

A number of recent price target changes have been made on Teladoc Health, including: Piper Sandler raises target price to $305 from $232D.A. Davidson raises...
Hapbee, Biotech Stock Review

Hapbee Technologies (HAPB): Updates and News Archive.

Recent Headlines UPDATED CONTINUOUSLY. June 4, 2021: Hapbee (HAPBF) Selects Accomplished Technology and Consumer Products Entrepreneur & Executive as CEO. May 27, 2021: Adding Hapbee Tech (HAPB,...
Hapbee, Biotech Stock Review

Hapbee (HAPB) Soars 136% the First Day of Trading!

LIVE QUOTE Subscribe here for upcoming report. Investors who participated in the recently closed Hapbee Technologies (HAPB) private placement in July at CDN $0.30 per share...
Hapbee, Biotech Stock Review

Telehealth App Hapbee (HAPB) Goes Public and More.

1. Hapbee (HAPB) $0.30, Going Public.2. Saying Goodbye to Immunomedics (IMMU) $86.3. Adding Biosig (BSGM) $2.95, to Watch List.4. Dalrada (DFCO) $0.11, Cancer Screening Test...
Hapbee,

Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

VANCOUVER, BC, Oct. 28, 2020 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) ("Hapbee" or the "Company"), a wellness technology company developing the revolutionary Hapbee...
Dalarada Health, Biotech Stock Review

Dalrada Cervical Cancer Testing Kit Study.

KEY TAKEAWAYS Dalrada Corp (DFCO) LIVE QUOTE This was admittedly a small test, with only 100 patients. But keep in mind in the first place, this isn't...
biotech stock review

Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’ Smear Test Screening.

DALRADA aims to introduce its VIA Test kit to females in India - of which there is 497 million. https://youtu.be/fXwvdN4XnKU In 2012, the U.S. Preventive...
Issam Radd

Citius Pharma (CTXR) Shareholder Letter | Year Ahead Roadmap.

2021 and 2020 Milestones In Plain Sight. Locked and Loaded for most of 2020 - many major milestone events lie around the corner for Citius...
Biosig

Adding BioSig (BSMG) $2.95 to Watch List.

Tough setback for newly launched Anti-Viral Endeavor ViralClear, Back to the Business of PURE EP™. LIVE QUOTE We've been following this great little technology company...

Latest article

Jeffrey Gundlach: Reckoning is Coming.

Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm. On 11 November 2020, Gundlach remarked in an interview with...

Who’s the Next Eric Sprott?

Eric Sprott, on Who is the Next Eric Sprott! To say Eric Sprott has left a legendary mark on the world of mining investment would...

Perpetua (PPTA) Raises $300 Million.

Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...